Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 158 articles:
HTML format
Text format



Single Articles


    May 2018
  1. MAO L, Chen Q, Gong K, Xu X, et al
    Berberine decelerates glucose metabolism via suppression of mTORdependent HIF1alpha protein synthesis in colon cancer cells.
    Oncol Rep. 2018;39:2436-2442.
    PubMed     Text format     Abstract available


  2. YU Y, Peng K, Li H, Zhuang R, et al
    SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer.
    Oncol Rep. 2018;39:2235-2242.
    PubMed     Text format     Abstract available


    March 2018
  3. REN W, Wang T, He X, Zhang Q, et al
    betaarrestin2 promotes 5FUinduced apoptosis via the NFkappaB pathway in colorectal cancer.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6340.
    PubMed     Text format     Abstract available


  4. LIU W, Li L, Ye H, Tao H, et al
    Role of COL6A3 in colorectal cancer.
    Oncol Rep. 2018 Mar 23. doi: 10.3892/or.2018.6331.
    PubMed     Text format     Abstract available


  5. PAN Y, Sun H, Hu X, He B, et al
    The inhibitory role of miR4855p in colorectal cancer proliferation and invasion via targeting of CD147.
    Oncol Rep. 2018 Mar 12. doi: 10.3892/or.2018.6309.
    PubMed     Text format     Abstract available


  6. QI C, Chen Y, Zhou Y, Huang X, et al
    Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Oncol Rep. 2018 Mar 8. doi: 10.3892/or.2018.6303.
    PubMed     Text format     Abstract available


  7. FUJINO S, Miyoshi N, Ohue M, Takahashi Y, et al
    Plateletderived growth factor receptorbeta gene expression relates to recurrence in colorectal cancer.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6290.
    PubMed     Text format     Abstract available


  8. PARK HS, Kim BC, Yeo HY, Kim KH, et al
    Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6287.
    PubMed     Text format     Abstract available


  9. KANEKIYO S, Hazama S, Takenouchi H, Nakajima M, et al
    IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6288.
    PubMed     Text format     Abstract available


    February 2018
  10. OKUGAWA Y, Yao L, Toiyama Y, Yamamoto A, et al
    Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients.
    Oncol Rep. 2018 Feb 14. doi: 10.3892/or.2018.6270.
    PubMed     Text format     Abstract available


  11. LI Y, Zhao L, Zhang Y, Guan L, et al
    Downregulation of the long non-coding RNA XLOC_010588 inhibits the invasion and migration of colorectal cancer.
    Oncol Rep. 2018 Feb 12. doi: 10.3892/or.2018.6260.
    PubMed     Text format     Abstract available


  12. SHEN L, Dong X, Wang Y, Qiu L, et al
    beta3GnT8 regulates oxaliplatin resistance by altering integrin beta1 glycosylation in colon cancer cells.
    Oncol Rep. 2018 Feb 1. doi: 10.3892/or.2018.6243.
    PubMed     Text format     Abstract available


    January 2018
  13. ENDO S, Fujita M, Yamada S, Imadome K, et al
    Fra1 enhances the radioresistance of colon cancer cells to Xray or Cion radiation.
    Oncol Rep. 2018 Jan 19. doi: 10.3892/or.2018.6223.
    PubMed     Text format     Abstract available


  14. XIONG Y, Wang J, Zhu H, Liu L, et al
    Chronic oxymatrine treatment induces resistance and epithelialmesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
    Oncol Rep. 2018 Jan 10. doi: 10.3892/or.2018.6204.
    PubMed     Text format     Abstract available


  15. GONG H, Fang L, Li Y, Du J, et al
    miR873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1.
    Oncol Rep. 2018 Jan 8. doi: 10.3892/or.2018.6199.
    PubMed     Text format     Abstract available


  16. KIM IH, Nam TJ
    Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6193.
    PubMed     Text format     Abstract available


  17. SHIMADA T, Tsuruta M, Hasegawa H, Okabayashi K, et al
    Heat shock protein 27 knockdown using nucleotidebased therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6180.
    PubMed     Text format     Abstract available


    December 2017
  18. ZHAO J, Xu J, Zhang R
    MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
    Oncol Rep. 2017 Dec 5. doi: 10.3892/or.2017.6135.
    PubMed     Text format     Abstract available


  19. YANG C, Wang MH, Zhou JD, Chi Q, et al
    Upregulation of miR-542-3p inhibits the growth and invasion of human colon cancer cells through PI3K/AKT/survivin signaling.
    Oncol Rep. 2017;38:3545-3553.
    PubMed     Text format     Abstract available


    November 2017
  20. CHEN M, Lin M, Wang X
    Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6110.
    PubMed     Text format     Abstract available


  21. RATTANAWONG A, Payon V, Limpanasittikul W, Boonkrai C, et al
    Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6084.
    PubMed     Text format     Abstract available


  22. LIN CS, Liu LT, Ou LH, Pan SC, et al
    Role of mitochondrial function in the invasiveness of human colon cancer cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6087.
    PubMed     Text format     Abstract available


  23. LI J, Li X, Cen C, Ai X, et al
    The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31.
    Oncol Rep. 2017 Nov 7. doi: 10.3892/or.2017.6082.
    PubMed     Text format     Abstract available


  24. WANG D, Rai B, Qi F, Liu T, et al
    Influence of the Twist gene on the invasion and metastasis of colon cancer.
    Oncol Rep. 2017 Nov 6. doi: 10.3892/or.2017.6076.
    PubMed     Text format     Abstract available


    October 2017
  25. ZHANG Y, Guo Y, Wang M, Dong H, et al
    Quercetrin from Toona sinensis leaves induces cell cycle arrest and apoptosis via enhancement of oxidative stress in human colorectal cancer SW620 cells.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6042.
    PubMed     Text format     Abstract available


  26. QUE K, Tong Y, Que G, Li L, et al
    Downregulation of miR-874-3p promotes chemotherapeutic resistance in colorectal cancer via inactivation of the Hippo signaling pathway.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6041.
    PubMed     Text format     Abstract available


  27. HE PY, Yip WK, Chai BL, Chai BY, et al
    Inhibition of cell migration and invasion by miR29a3p in a colorectal cancer cell line through suppression of CDC42BPA mRNA expression.
    Oncol Rep. 2017 Oct 16. doi: 10.3892/or.2017.6037.
    PubMed     Text format     Abstract available


  28. TIAN XQ, Guo FF, Sun DF, Wang YC, et al
    Downregulation of ZNF278 arrests the cell cycle and decreases the proliferation of colorectal cancer cells via inhibition of the ERK/MAPK pathway.
    Oncol Rep. 2017 Oct 12. doi: 10.3892/or.2017.6031.
    PubMed     Text format     Abstract available


  29. LI X, Yang H, Ke J, Liu B, et al
    Smad4 re-expression increases the sensitivity to parthenolide in colorectal cancer.
    Oncol Rep. 2017;38:2317-2324.
    PubMed     Text format     Abstract available


  30. WU S, Wu F, Jiang Z
    Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
    Oncol Rep. 2017;38:2043-2050.
    PubMed     Text format     Abstract available


    September 2017
  31. LI K, Na K, Sang T, Wu K, et al
    The ethanol extracts of sporoderm-broken spores of Ganoderma lucidum inhibit colorectal cancer in vitro and in vivo.
    Oncol Rep. 2017 Sep 27. doi: 10.3892/or.2017.6010.
    PubMed     Text format     Abstract available


  32. LIU X, Wang Y, Zhao J
    MicroRNA337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5997.
    PubMed     Text format     Abstract available


  33. LI Y, Wang C, Li D, Deng P, et al
    1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
    Oncol Rep. 2017 Sep 13. doi: 10.3892/or.2017.5954.
    PubMed     Text format     Abstract available


  34. FEI R, Zhang Y, Wang S, Xiang T, et al
    alpha7 nicotinic acetylcholine receptor in tumor-associated macrophages inhibits colorectal cancer metastasis through the JAK2/STAT3 signaling pathway.
    Oncol Rep. 2017 Sep 4. doi: 10.3892/or.2017.5935.
    PubMed     Text format     Abstract available


    August 2017
  35. TANG X, Zha L, Li H, Liao G, et al
    Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/beta-catenin signaling pathway.
    Oncol Rep. 2017 Aug 25. doi: 10.3892/or.2017.5923.
    PubMed     Text format     Abstract available


  36. SUI H, Duan P, Guo P, Hao L, et al
    Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancer.
    Oncol Rep. 2017 Aug 23. doi: 10.3892/or.2017.5917.
    PubMed     Text format     Abstract available


  37. CHEN LD, Liu ZH, Zhang LF, Yao JN, et al
    Sanggenon C induces apoptosis of colon cancer cells via inhibition of NO production, iNOS expression and ROS activation of the mitochondrial pathway.
    Oncol Rep. 2017 Aug 22. doi: 10.3892/or.2017.5912.
    PubMed     Text format     Abstract available


  38. WU W, Chen J, Wu J, Lin J, et al
    Knockdown of tripartite motif-59 inhibits the malignant processes in human colorectal cancer cells.
    Oncol Rep. 2017 Aug 10. doi: 10.3892/or.2017.5896.
    PubMed     Text format     Abstract available


  39. LIN J, Feng J, Yang H, Yan Z, et al
    Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway.
    Oncol Rep. 2017 Aug 9. doi: 10.3892/or.2017.5892.
    PubMed     Text format     Abstract available


  40. WANG M, He SF, Liu LL, Sun XX, et al
    Potential role of ZEB1 as a DNA repair regulator in colorectal cancer cells revealed by cancer-associated promoter profiling.
    Oncol Rep. 2017 Aug 8. doi: 10.3892/or.2017.5888.
    PubMed     Text format     Abstract available


    July 2017
  41. LI S, Yang G, Zhu X, Cheng L, et al
    Combination of rapamycin and garlic-derived S-allylmercaptocysteine induces colon cancer cell apoptosis and suppresses tumor growth in xenograft nude mice through autophagy/p62/Nrf2 pathway.
    Oncol Rep. 2017 Jul 24. doi: 10.3892/or.2017.5849.
    PubMed     Text format     Abstract available


  42. YAN W, Bai Z, Wang J, Li X, et al
    ANP32A modulates cell growth by regulating p38 and Akt activity in colorectal cancer.
    Oncol Rep. 2017 Jul 21. doi: 10.3892/or.2017.5845.
    PubMed     Text format     Abstract available


  43. HUANG W, Tian Y, Dong S, Cha Y, et al
    The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5837.
    PubMed     Text format     Abstract available


  44. HWANG NL, Kang YJ, Sung B, Hwang SY, et al
    MHY451 induces cell cycle arrest and apoptosis by ROS generation in HCT116 human colorectal cancer cells.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5836.
    PubMed     Text format     Abstract available


  45. SUN J, Xu K, Qiu Y, Gao H, et al
    Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells.
    Oncol Rep. 2017 Jul 17. doi: 10.3892/or.2017.5826.
    PubMed     Text format     Abstract available


  46. LEE MS, Kim MS, Yoo JK, Lee JY, et al
    Enhanced anticancer effects of a mixture of low-dose mushrooms and Panax ginseng root extracts in human colorectal cancer cells.
    Oncol Rep. 2017 Jul 7. doi: 10.3892/or.2017.5796.
    PubMed     Text format     Abstract available


  47. WANG HG, Cao B, Zhang LX, Song N, et al
    KLF2 inhibits cell growth via regulating HIF-1alpha/Notch-1 signal pathway in human colorectal cancer HCT116 cells.
    Oncol Rep. 2017;38:584-590.
    PubMed     Text format     Abstract available


    June 2017
  48. MA Y, Wu L, Liu X, Xu Y, et al
    KLF4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling.
    Oncol Rep. 2017 Jun 21. doi: 10.3892/or.2017.5736.
    PubMed     Text format     Abstract available


  49. ISHIDA T, Ishii Y, Tsuruta M, Okabayashi K, et al
    Cetuximab promotes SN38 sensitivity via suppression of heat shock protein 27 in colorectal cancer cells with wild-type RAS.
    Oncol Rep. 2017 Jun 21. doi: 10.3892/or.2017.5734.
    PubMed     Text format     Abstract available


  50. ALTOBELLI E, Latella G, Morroni M, Licini C, et al
    Low HtrA1 expression in patients with longstanding ulcerative colitis and colorectal cancer.
    Oncol Rep. 2017 Jun 6. doi: 10.3892/or.2017.5700.
    PubMed     Text format     Abstract available


  51. DE ALMEIDA CV, Zamame JA, Romagnoli GG, Rodrigues CP, et al
    Treatment of colon cancer cells with 5-fluorouracil can improve the effectiveness of RNA-transfected antitumor dendritic cell vaccine.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5692.
    PubMed     Text format     Abstract available


  52. ZHANG X, Sukamporn P, Zhang S, Min KW, et al
    3,3'-diindolylmethane downregulates cyclin D1 through triggering endoplasmic reticulum stress in colorectal cancer cells.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5693.
    PubMed     Text format     Abstract available


  53. KOWALCZYK AE, Krazinski BE, Godlewski J, Kiewisz J, et al
    Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5687.
    PubMed     Text format     Abstract available


    May 2017
  54. CUYAS E, Queralt B, Martin-Castillo B, Bosch-Barrera J, et al
    EphA2 receptor activation with ephrin-A1 ligand restores cetuximab efficacy in NRAS-mutant colorectal cancer cells.
    Oncol Rep. 2017 May 30. doi: 10.3892/or.2017.5682.
    PubMed     Text format     Abstract available


  55. WANG W, Deng J, Wang Q, Yao Q, et al
    Synergistic role of Cul1 and c-Myc: Prognostic and predictive biomarkers in colorectal cancer.
    Oncol Rep. 2017 May 25. doi: 10.3892/or.2017.5671.
    PubMed     Text format     Abstract available


  56. CHEN LG, Xia YJ, Cui Y
    Upregulation of miR-101 enhances the cytotoxic effect of anticancer drugs through inhibition of colon cancer cell proliferation.
    Oncol Rep. 2017 May 24. doi: 10.3892/or.2017.5666.
    PubMed     Text format     Abstract available


  57. ZENG YH, Zhou LY, Chen QZ, Li Y, et al
    Resveratrol inactivates PI3K/Akt signaling through upregulating BMP7 in human colon cancer cells.
    Oncol Rep. 2017 May 23. doi: 10.3892/or.2017.5662.
    PubMed     Text format     Abstract available


  58. SUN Y, Ji B, Feng Y, Zhang Y, et al
    TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
    Oncol Rep. 2017 May 22. doi: 10.3892/or.2017.5654.
    PubMed     Text format     Abstract available


  59. ZHANG L, Fang Y, Feng JY, Cai QY, et al
    Chloroform fraction of Scutellaria barbata D. Don inhibits the growth of colorectal cancer cells by activating miR34a.
    Oncol Rep. 2017 May 4. doi: 10.3892/or.2017.5625.
    PubMed     Text format     Abstract available


  60. YE M, He Y, Lin H, Yang S, et al
    High expression of atonal homolog 8 predicts a poor clinical outcome in patients with colorectal cancer and contributes to tumor progression.
    Oncol Rep. 2017;37:2955-2963.
    PubMed     Text format     Abstract available


  61. ARRIAGA JM, Bravo AI, Mordoh J, Bianchini M, et al
    Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells.
    Oncol Rep. 2017;37:2633-2651.
    PubMed     Text format     Abstract available


  62. ANUPAMA S, Laha P, Sharma M, Pathak K, et al
    Pharmacokinetics, biodistribution and antitumour effects of Sclerotium rolfsii lectin in mice.
    Oncol Rep. 2017;37:2803-2810.
    PubMed     Text format     Abstract available


    April 2017
  63. WEN L, Li Y, Jiang Z, Zhang Y, et al
    miR-944 inhibits cell migration and invasion by targeting MACC1 in colorectal cancer.
    Oncol Rep. 2017 Apr 28. doi: 10.3892/or.2017.5611.
    PubMed     Text format     Abstract available


  64. WANG Y, Lu Z, Wang N, Zhang M, et al
    MicroRNA-1299 is a negative regulator of STAT3 in colon cancer.
    Oncol Rep. 2017 Apr 26. doi: 10.3892/or.2017.5605.
    PubMed     Text format     Abstract available


  65. LIU W, Qian K, Wei X, Deng H, et al
    miR27a promotes proliferation, migration, and invasion of colorectal cancer by targeting FAM172A and acts as a diagnostic and prognostic biomarker.
    Oncol Rep. 2017 Apr 20. doi: 10.3892/or.2017.5592.
    PubMed     Text format     Abstract available


  66. ZHANG Y, Fang F, Fan K, Zhang Y, et al
    Effective cytotoxic activity of OSW-1 on colon cancer by inducing apoptosis in vitro and in vivo.
    Oncol Rep. 2017 Apr 19. doi: 10.3892/or.2017.5582.
    PubMed     Text format     Abstract available


  67. ABDULLA MH, Valli-Mohammed MA, Al-Khayal K, Al Shkieh A, et al
    Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages.
    Oncol Rep. 2017 Apr 18. doi: 10.3892/or.2017.5576.
    PubMed     Text format     Abstract available


  68. WANG H, Li S, Luo X, Song Z, et al
    Knockdown of PARP6 or survivin promotes cell apoptosis and inhibits cell invasion of colorectal adenocarcinoma cells.
    Oncol Rep. 2017;37:2245-2251.
    PubMed     Text format     Abstract available


  69. LUPUT L, Licarete E, Sesarman A, Patras L, et al
    Tumor-associated macrophages favor C26 murine colon carcinoma cell proliferation in an oxidative stress-dependent manner.
    Oncol Rep. 2017;37:2472-2480.
    PubMed     Text format     Abstract available


  70. KAKIZAWA N, Suzuki K, Fukui T, Takayama Y, et al
    Clinical and molecular assessment of regorafenib monotherapy.
    Oncol Rep. 2017;37:2506-2512.
    PubMed     Text format     Abstract available


  71. WANG YP, Guo PT, Zhu Z, Zhang H, et al
    Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/beta-catenin signaling pathway in human colorectal adenocarcinoma.
    Oncol Rep. 2017;37:1961-1970.
    PubMed     Text format     Abstract available


    March 2017
  72. AL BANDAR MH, Kim NK
    Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review).
    Oncol Rep. 2017 Mar 27. doi: 10.3892/or.2017.5531.
    PubMed     Text format     Abstract available


  73. KAWASAKI H, Saotome T, Usui T, Ohama T, et al
    Regulation of intestinal myofibroblasts by KRas-mutated colorectal cancer cells through heparin-binding epidermal growth factor-like growth factor.
    Oncol Rep. 2017 Mar 22. doi: 10.3892/or.2017.5520.
    PubMed     Text format     Abstract available


  74. GUO F, Chen JJ, Tang WJ
    CIRH1A augments the proliferation of RKO colorectal cancer cells.
    Oncol Rep. 2017 Mar 8. doi: 10.3892/or.2017.5497.
    PubMed     Text format     Abstract available


  75. YUAN Z, Shi X, Qiu Y, Jia T, et al
    Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin.
    Oncol Rep. 2017;37:1815-1825.
    PubMed     Text format     Abstract available


  76. LIN XY, Chen SZ
    Calpain inhibitors ameliorate muscle wasting in a cachectic mouse model bearing CT26 colorectal adenocarcinoma.
    Oncol Rep. 2017;37:1601-1610.
    PubMed     Text format     Abstract available


  77. HUANG C, Liu H, Gong XL, Wu LY, et al
    Effect of evodiamine and berberine on the interaction between DNMTs and target microRNAs during malignant transformation of the colon by TGF-beta1.
    Oncol Rep. 2017;37:1637-1645.
    PubMed     Text format     Abstract available


  78. FU Y, Liu Y, Wang J, Li C, et al
    Calcium release induced by 2-pyridinecarboxaldehyde thiosemicarbazone and its copper complex contributes to tumor cell death.
    Oncol Rep. 2017;37:1662-1670.
    PubMed     Text format     Abstract available


    February 2017
  79. YUAN X, Sun X, Shi X, Wang H, et al
    USP39 promotes colorectal cancer growth and metastasis through the Wnt/beta-catenin pathway.
    Oncol Rep. 2017 Feb 15. doi: 10.3892/or.2017.5454.
    PubMed     Text format     Abstract available


  80. DAI X, Liu J, Nian Y, Qiu MH, et al
    A novel cycloartane triterpenoid from Cimicifuga induces apoptotic and autophagic cell death in human colon cancer HT-29 cells.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5444.
    PubMed     Text format     Abstract available


  81. SHEN T, Yang Z, Cheng X, Xiao Y, et al
    CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-kappaB signaling pathway.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5453.
    PubMed     Text format     Abstract available


  82. CHAI Y, Xu J, Yan B
    The anti-metastatic effect of baicalein on colorectal cancer.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5437.
    PubMed     Text format     Abstract available


  83. SHOJI H, Motegi M, Takakusagi Y, Asao T, et al
    Chemoradiotherapy and concurrent radiofrequency thermal therapy to treat primary rectal cancer and prediction of treatment responses.
    Oncol Rep. 2017;37:695-704.
    PubMed     Text format     Abstract available


  84. WANG X, Liu C, Wang J, Fan Y, et al
    Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-beta1/Smad signaling pathway.
    Oncol Rep. 2017;37:747-753.
    PubMed     Text format     Abstract available


    January 2017
  85. SAETANG J, Sangkhathat S
    Diets link metabolic syndrome and colorectal cancer development (Review).
    Oncol Rep. 2017 Jan 18. doi: 10.3892/or.2017.5385.
    PubMed     Text format     Abstract available


  86. CHEN Y, Zhang Y, He J, Fu Y, et al
    MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
    Oncol Rep. 2017 Jan 16. doi: 10.3892/or.2017.5371.
    PubMed     Text format     Abstract available


  87. WANG H, Chen Z, Chang H, Mu X, et al
    Expression of glia maturation factor gamma is associated with colorectal cancer metastasis and its downregulation suppresses colorectal cancer cell migration and invasion in vitro.
    Oncol Rep. 2017 Jan 9. doi: 10.3892/or.2017.5361.
    PubMed     Text format     Abstract available


  88. JANOWSKI E, Timofeeva O, Chasovskikh S, Goldberg M, et al
    Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies.
    Oncol Rep. 2017;37:57-65.
    PubMed     Text format     Abstract available


  89. HUANG G, Chen X, Cai Y, Wang X, et al
    miR-20a-directed regulation of BID is associated with the TRAIL sensitivity in colorectal cancer.
    Oncol Rep. 2017;37:571-578.
    PubMed     Text format     Abstract available


    December 2016
  90. FUJIYOSHI K, Yamamoto G, Takahashi A, Arai Y, et al
    High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5323.
    PubMed     Text format     Abstract available


  91. WANG T, Ning K, Lu TX, Hua D, et al
    Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5322.
    PubMed     Text format     Abstract available


  92. ZHANG C, Gong P, Liu P, Zhou N, et al
    Thioridazine elicits potent antitumor effects in colorectal cancer stem cells.
    Oncol Rep. 2016 Dec 14. doi: 10.3892/or.2016.5313.
    PubMed     Text format     Abstract available


    November 2016
  93. KIJIMA T, Hazama S, Tsunedomi R, Tanaka H, et al
    MicroRNA-6826 and -6875 in plasma are valuable noninvasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer.
    Oncol Rep. 2016 Nov 22. doi: 10.3892/or.2016.5267.
    PubMed     Text format     Abstract available


  94. MIYO M, Konno M, Colvin H, Nishida N, et al
    The importance of mitochondrial folate enzymes in human colorectal cancer.
    Oncol Rep. 2016 Nov 22. doi: 10.3892/or.2016.5264.
    PubMed     Text format     Abstract available


  95. FU Q, Cheng J, Zhang J, Zhang Y, et al
    miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer.
    Oncol Rep. 2016 Nov 18. doi: 10.3892/or.2016.5259.
    PubMed     Text format     Abstract available


  96. JIANG D, Wang L, Zhao T, Zhang Z, et al
    Restoration of the tumor-suppressor function to mutant p53 by Ganoderma lucidum polysaccharides in colorectal cancer cells.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5246.
    PubMed     Text format     Abstract available


  97. WEN W, Liu G, Jin K, Hu X, et al
    TGF-beta1 induces PGP9.5 expression in CAFs to promote the growth of colorectal cancer cells.
    Oncol Rep. 2016 Nov 9. doi: 10.3892/or.2016.5238.
    PubMed     Text format     Abstract available


  98. ZHAO M, Yu Z, Li Z, Tang J, et al
    Expression of angiogenic growth factors VEGF, bFGF and ANG1 in colon cancer after bevacizumab treatment in vitro: A potential self-regulating mechanism.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5231.
    PubMed     Text format     Abstract available


  99. LIU N, Li J, Zhao Z, Han J, et al
    MicroRNA-302a enhances 5-fluorouracil-induced cell death in human colon cancer cells.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5237.
    PubMed     Text format     Abstract available


  100. ONOZAWA H, Saito M, Saito K, Kanke Y, et al
    Annexin A1 is involved in resistance to 5-FU in colon cancer cells.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5234.
    PubMed     Text format     Abstract available


  101. ZHAO J, Lv Y, Cai Y, Wei W, et al
    Hyperthermic carbon dioxide pneumoperitoneum reinforces the inhibition of 5-FU on the proliferation and invasion of colon cancer.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5229.
    PubMed     Text format     Abstract available


  102. HUANG HL, Chen WC, Hsu HP, Cho CY, et al
    Silencing of argininosuccinate lyase inhibits colorectal cancer formation.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5221.
    PubMed     Text format     Abstract available


  103. KIM DH, Kim MJ, Sung B, Suh H, et al
    Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5219.
    PubMed     Text format     Abstract available


  104. LEE CY, Hsieh SL, Hsieh S, Tsai CC, et al
    Inhibition of human colorectal cancer metastasis by notoginsenoside R1, an important compound from Panax notoginseng.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5222.
    PubMed     Text format     Abstract available


  105. GAO L, Zhou Y, Zhou SX, Yu XJ, et al
    PLD4 promotes M1 macrophages to perform antitumor effects in colon cancer cells.
    Oncol Rep. 2016 Nov 3. doi: 10.3892/or.2016.5216.
    PubMed     Text format     Abstract available


  106. WANG C, Guo D, Wang Q, You S, et al
    Aliskiren targets multiple systems to alleviate cancer cachexia.
    Oncol Rep. 2016;36:3014-3022.
    PubMed     Text format     Abstract available


  107. ZHOU X, Xing X, Zhang S, Liu L, et al
    Glucose-regulated protein 78 contributes to the proliferation and tumorigenesis of human colorectal carcinoma via AKT and ERK pathways.
    Oncol Rep. 2016;36:2723-2730.
    PubMed     Text format     Abstract available


  108. YASSIN S, Hu J, Xu H, Li C, et al
    In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT116 xenograft model in nude mice.
    Oncol Rep. 2016;36:2951-2959.
    PubMed     Text format     Abstract available


  109. LAGERSTEDT-ROBINSON K, Rohlin A, Aravidis C, Melin B, et al
    Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Oncol Rep. 2016;36:2823-2835.
    PubMed     Text format     Abstract available


    October 2016
  110. SUZUKI N, Nakagawa F, Matsuoka K, Takechi T, et al
    Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts.
    Oncol Rep. 2016 Oct 27. doi: 10.3892/or.2016.5208.
    PubMed     Text format     Abstract available


  111. WU H, Cheng X, Ji X, He Y, et al
    Cortactin contributes to the tumorigenicity of colorectal cancer by promoting cell proliferation.
    Oncol Rep. 2016 Oct 27. doi: 10.3892/or.2016.5207.
    PubMed     Text format     Abstract available


  112. RIFFO-CAMPOS AL, Castillo J, Vallet-Sanchez A, Ayala G, et al
    In silico RNA-seq and experimental analyses reveal the differential expression and splicing of EPDR1 and ZNF518B genes in relation to KRAS mutations in colorectal cancer cells.
    Oncol Rep. 2016 Oct 27. doi: 10.3892/or.2016.5210.
    PubMed     Text format     Abstract available


  113. TAKATSUNA M, Morohashi S, Yoshizawa T, Hirai H, et al
    Myofibroblast distribution is associated with invasive growth types of colorectal cancer.
    Oncol Rep. 2016 Oct 25. doi: 10.3892/or.2016.5202.
    PubMed     Text format     Abstract available


  114. FU Q, Cheng J, Zhang J, Zhang Y, et al
    Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5195.
    PubMed     Text format     Abstract available


  115. WANG L, Yu P
    miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5193.
    PubMed     Text format     Abstract available


  116. ZHANG Y, Yuan J, Zhang X, Yan F, et al
    Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5194.
    PubMed     Text format     Abstract available


  117. LIN J, Feng J, Jin Y, Yan Z, et al
    Pien Tze Huang suppresses VEGF-C-mediated lymphangiogenesis in colorectal cancer.
    Oncol Rep. 2016 Oct 20. doi: 10.3892/or.2016.5186.
    PubMed     Text format     Abstract available


  118. MARLICZ W, Sielatycka K, Serwin K, Kubis E, et al
    Effect of colorectal cancer on the number of normal stem cells circulating in peripheral blood.
    Oncol Rep. 2016 Oct 18. doi: 10.3892/or.2016.5179.
    PubMed     Text format     Abstract available


  119. ZHOU X, Wang P, Zhang YJ, Xu JJ, et al
    Comparative proteomic analysis of melanosis coli with colon cancer.
    Oncol Rep. 2016 Oct 17. doi: 10.3892/or.2016.5178.
    PubMed     Text format     Abstract available


  120. YI W, Xiao E, Ding R, Luo P, et al
    High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-kappaB/p53-apoptosis signaling pathway in colorectal cancer.
    Oncol Rep. 2016 Oct 17. doi: 10.3892/or.2016.5177.
    PubMed     Text format     Abstract available


  121. ZHANG H, Qiao L, Li X, Wan Y, et al
    Tissue metabolic profiling of lymph node metastasis of colorectal cancer assessed by 1H NMR.
    Oncol Rep. 2016 Oct 14. doi: 10.3892/or.2016.5175.
    PubMed     Text format     Abstract available


  122. CHEN F, Sun G, Peng J
    RNAi-mediated HOXD3 knockdown inhibits growth in human RKO cells.
    Oncol Rep. 2016;36:1793-8.
    PubMed     Text format     Abstract available


  123. TIAN X, Yan L, Zhang D, Guan X, et al
    PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
    Oncol Rep. 2016;36:1829-36.
    PubMed     Text format     Abstract available


    September 2016
  124. FAN XJ, Wang Y, Wang L, Zhu M, et al
    Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway.
    Oncol Rep. 2016 Sep 30. doi: 10.3892/or.2016.5138.
    PubMed     Text format     Abstract available


  125. HOLZNER S, Senfter D, Stadler S, Staribacher A, et al
    Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro.
    Oncol Rep. 2016 Sep 20. doi: 10.3892/or.2016.5114.
    PubMed     Text format     Abstract available


  126. HUANG C, Liu H, Gong XL, Wu L, et al
    Expression of DNA methyltransferases and target microRNAs in human tissue samples related to sporadic colorectal cancer.
    Oncol Rep. 2016 Sep 19. doi: 10.3892/or.2016.5104.
    PubMed     Text format     Abstract available


  127. YOO HI, Kim BK, Yoon SK
    MicroRNA-330-5p negatively regulates ITGA5 expression in human colorectal cancer.
    Oncol Rep. 2016 Sep 15. doi: 10.3892/or.2016.5092.
    PubMed     Text format     Abstract available


  128. KIM BR, Kang MH, Kim JL, Na YJ, et al
    RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer.
    Oncol Rep. 2016 Sep 12. doi: 10.3892/or.2016.5086.
    PubMed     Text format     Abstract available


    August 2016
  129. JING X, Wu H, Ji X, Wu H, et al
    Cortactin promotes cell migration and invasion through upregulation of the dedicator of cytokinesis 1 expression in human colorectal cancer.
    Oncol Rep. 2016 Aug 31. doi: 10.3892/or.2016.5058.
    PubMed     Text format     Abstract available


  130. LI S, Wu X, Xu Y, Wu S, et al
    miR-145 suppresses colorectal cancer cell migration and invasion by targeting an ETS-related gene.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5042.
    PubMed     Text format     Abstract available


  131. WU Y, Xie R, Liu X, Wang J, et al
    Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5041.
    PubMed     Text format     Abstract available


  132. ZHANG SS, Huang ZW, Li LX, Fu JJ, et al
    Identification of CD200+ colorectal cancer stem cells and their gene expression profile.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5039.
    PubMed     Text format     Abstract available


  133. RUWAN KUMARA MH, Piao MJ, Kang KA, Ryu YS, et al
    Non-thermal gas plasma-induced endoplasmic reticulum stress mediates apoptosis in human colon cancer cells.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5038.
    PubMed     Text format     Abstract available


  134. ACQUAVIVA R, Sorrenti V, Santangelo R, Cardile V, et al
    Effects of an extract of Celtis aetnensis (Tornab.) Strobl twigs on human colon cancer cell cultures.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5035.
    PubMed     Text format     Abstract available


  135. XIONG W, Gao D, Li Y, Liu X, et al
    Genome-wide profiling of chemoradiationinduced changes in alternative splicing in colon cancer cells.
    Oncol Rep. 2016 Aug 12. doi: 10.3892/or.2016.5022.
    PubMed     Text format     Abstract available


  136. OKADA K, Hakata S, Terashima J, Gamou T, et al
    Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
    Oncol Rep. 2016 Aug 8. doi: 10.3892/or.2016.5008.
    PubMed     Text format     Abstract available


    July 2016
  137. XU K, Wang J, Gao J, Di J, et al
    GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer.
    Oncol Rep. 2016 Jul 21. doi: 10.3892/or.2016.4961.
    PubMed     Text format     Abstract available


  138. XU W, Xu B, Yao Y, Yu X, et al
    RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4941.
    PubMed     Text format     Abstract available


  139. WEI H, Cheng Z, Ouyang C, Zhang Y, et al
    Glycoprotein screening in colorectal cancer based on differentially expressed Tn antigen.
    Oncol Rep. 2016 Jul 14. doi: 10.3892/or.2016.4937.
    PubMed     Text format     Abstract available


  140. TAKATSUNA M, Morohashi S, Yoshizawa T, Hirai H, et al
    Myofibroblasts of the muscle layer stimulate the malignant potential of colorectal cancer.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4932.
    PubMed     Text format     Abstract available


  141. ZHU L, Tian G, Yang Q, De G, et al
    Thyroid hormone receptor beta1 suppresses proliferation and migration by inhibiting PI3K/Akt signaling in human colorectal cancer cells.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4931.
    PubMed     Text format     Abstract available


  142. LIANG L, Huang J
    Oxymatrine inhibits epithelial-mesenchymal transition through regulation of NF-kappaB signaling in colorectal cancer cells.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4927.
    PubMed     Text format     Abstract available


  143. SUN ZZ, Zhang T, Ning K, Zhu R, et al
    B7-H3 upregulates BRCC3 expression, antagonizing DNA damage caused by 5-Fu.
    Oncol Rep. 2016;36:231-8.
    PubMed     Text format     Abstract available


  144. ZHANG Y, Lin L, Jin Y, Lin Y, et al
    Overexpression of WNT5B promotes COLO 205 cell migration and invasion through the JNK signaling pathway.
    Oncol Rep. 2016;36:23-30.
    PubMed     Text format     Abstract available


    June 2016
  145. IWAI T, Sugimoto M, Harada S, Yorozu K, et al
    Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model.
    Oncol Rep. 2016 Jun 22. doi: 10.3892/or.2016.4902.
    PubMed     Text format     Abstract available


  146. KIM EH, Lee H, Jeong YK, Jung WG, et al
    Mechanisms of SU5416, an inhibitor of vascular endothelial growth factor receptor, as a radiosensitizer for colon cancer cells.
    Oncol Rep. 2016 Jun 10. doi: 10.3892/or.2016.4868.
    PubMed     Text format     Abstract available


  147. LIU J, Li Q, Liu Z, Lin L, et al
    Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the Akt and ERK signaling pathways.
    Oncol Rep. 2016;35:3363-70.
    PubMed     Text format     Abstract available


    May 2016
  148. KANG HR, Choi HG, Jeon CK, Lim SJ, et al
    Butyrate-mediated acquisition of chemoresistance by human colon cancer cells.
    Oncol Rep. 2016 May 27. doi: 10.3892/or.2016.4838.
    PubMed     Text format     Abstract available


  149. CUI F, Wang S, Lao I, Zhou C, et al
    miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
    Oncol Rep. 2016 May 24. doi: 10.3892/or.2016.4834.
    PubMed     Text format     Abstract available


  150. LEE MH, Hong SH, Park C, Kim GY, et al
    Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway.
    Oncol Rep. 2016 May 17. doi: 10.3892/or.2016.4812.
    PubMed     Text format     Abstract available


  151. HAN J, Liu Z, Wang N, Pan W, et al
    MicroRNA-874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X-linked inhibitor of apoptosis protein.
    Oncol Rep. 2016 May 16. doi: 10.3892/or.2016.4810.
    PubMed     Text format     Abstract available


  152. ZHA H, Sun H, Li X, Duan L, et al
    S100A8 facilitates the migration of colorectal cancer cells through regulating macrophages in the inflammatory microenvironment.
    Oncol Rep. 2016 May 6. doi: 10.3892/or.2016.4790.
    PubMed     Text format     Abstract available


  153. SHOJI H, Motegi M, Osawa K, Okonogi N, et al
    Radiofrequency thermal treatment with chemoradiotherapy for advanced rectal cancer.
    Oncol Rep. 2016;35:2569-75.
    PubMed     Text format     Abstract available


    April 2016
  154. PONNUSAMY S, Lattmann E, Lattmann P, Thiyagarajan T, et al
    Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action.
    Oncol Rep. 2016;35:2097-106.
    PubMed     Text format     Abstract available


    March 2016
  155. KIM A, Im M, Ma JY
    Sosihotang ameliorates cachexiarelated symptoms in mice bearing colon 26 adenocarcinoma by reducing systemic inflammation and muscle loss.
    Oncol Rep. 2016;35:1841-50.
    PubMed     Text format     Abstract available


    February 2016
  156. YORIFUJI N, Inoue T, Iguchi M, Fujiwara K, et al
    The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice.
    Oncol Rep. 2016;35:676-82.
    PubMed     Text format     Abstract available


    January 2016
  157. KASAI C, Sugimoto K, Moritani I, Tanaka J, et al
    Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.
    Oncol Rep. 2016;35:325-33.
    PubMed     Text format     Abstract available


  158. WENG WH, Leung WH, Pang YJ, Hsu HH, et al
    Lauric acid can improve the sensitization of Cetuximab in KRAS/BRAF mutated colorectal cancer cells by retrievable microRNA-378 expression.
    Oncol Rep. 2016;35:107-16.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: